Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

 AMSTERDAM & ZUG, Switzerland & GDAŃSK, Poland - Tuesday, 02. September 2025 AETOSWire Print 

(BUSINESS WIRE) -- Polpharma Biologics S.A. (“Polpharma Biologics”), specialized in the development and manufacturing of biosimilars, today announced that it has signed licensing agreements with MS Pharma, a leading biosimilar production and distribution company in the Middle East and North Africa (MENA) region, for the commercialization of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.

Under the agreements, MS Pharma will be responsible for the registration, marketing, and distribution of these three biosimilars across MENA, while Polpharma Biologics will maintain responsibility for development, manufacturing, and supply. Furthermore, both Parties have agreed to transfer fill and finish activities to the MENA region. These operations will be carried out at MS Pharma’s first of its kind biologics manufacturing facility in Saudi Arabia.

Vedolizumab is a monoclonal antibody targeting α4β7 integrin (a molecule involved in the movement of immune cells to the gut), indicated for ulcerative colitis and Crohn’s disease. Ocrelizumab targets CD20-positive B cells, and by depleting them, helps reduce inflammation and slow the progression of disability in people with multiple sclerosis. Guselkumab - monoclonal antibody that selectively binds to the p19 subunit of interleukin-23 (IL-23), a key cytokine involved in inflammatory and immune responses. It is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.

Together, these biosimilars represent significant potential to expand access to high-quality, affordable biologic therapies for patients in the region.

Kalle Känd, CEO of MS Pharma:

"Expanding our biosimilar portfolio in high-need therapeutic areas such as gastroenterology, neurology, and dermatology is a strategic priority. These three products will significantly strengthen our offering and reinforce our leadership in the MENA region. Partnering once again with Polpharma Biologics underscores our commitment to delivering high-quality, accessible biologic medicines to patients across the region, through localizing advanced biologics production."

Konstantin Matentzoglu, Supervisory Board Member of Polpharma Biologics Group:

"We are proud to extend our collaboration with MS Pharma. Their deep regional expertise and strong commercial network make them an ideal partner to bring our biosimilar medicines to more patients in MENA, helping improve treatment accessibility and sustainability of healthcare systems."

About MS Pharma

MS Pharma is a leading regional pharmaceutical company in the MENA region, specializing in the development, production, and distribution of a broad portfolio of generic and biologic therapies. Positioned for rapid growth, the company operates five manufacturing facilities across Jordan, Algeria, and Saudi Arabia — home to a newly launched biologics plant, all serving the broader MENA market. Headquartered in Amman, Jordan, with management offices in Zug, Switzerland, MS Pharma employs over 2,000 people across 12 countries.

For more information, please visit http://www.mspharma.com

About Polpharma Biologics

Polpharma Biologics is an international biotechnology company with integrated operations in the European Union (EU), developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas.

Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production preparing drugs for future commercial partnerships with global pharmaceutical organizations. The expertise of Polpharma Biologics lies in the development and manufacture of medicines based on microbial and mammalian expression systems. With its cell line development center in the Netherlands and two centers of development and manufacturing in Poland, Polpharma Biologics creates growth and development opportunities for biotechnology specialists.

Learn more at www.polpharmabiologics.com

Important Note

This press release is for informational purposes only and does not constitute promotional material for PB016, PB018 and PB019 in Poland or any other jurisdiction. The commercialization of proposed vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) biosimilars is solely the responsibility of MS Pharma, the marketing authorization holder, in accordance with all applicable laws and regulations.

Disclaimer

This press release is issued from Polpharma Biologics Group and is intended to provide worldwide information to healthcare professionals, media and (potential) investors about our global business in relation to drug development and manufacturing expertise. Although Polpharma Biologics Group is not a public company as of this date, recipients should understand that this press release contains certain forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). These statements involve inherent risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the approval and commercialization of the medicinal product, market reception, competition, changes in economic conditions and applicable laws, global regulatory developments, contractual risks and dependencies from third parties. Polpharma Biologics undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release. Moreover, Polpharma Biologics wishes to emphasize that this press release is for informational purposes only and shall not be construed as making any representation, warranties, or guarantees, either express or implied, regarding the potential approval, market reception, commercialization, or success of the medicinal product or any other product or therapy.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250902492755/en/

Permalink

https://www.aetoswire.com/en/news/0209202548716

Contacts

Media contacts:

Polpharma Biologics

Natalia Kwiecień

natalia.kwiecien@polpharmabiologics.com

MS Pharma

Orayb Akeel

+ (962) 65 827 999

communication@mspharma.com

Klay Group Appoints Ahmad Chaudry as the Global Head of Structured Investments & Derivatives

 Klay Group, a boutique financial services firm providing Wealth Management, Multi-Family Office, Asset Management and Corporate Advisory services to ultra-high-net-worth families and institutions, today announced the appointment of Ahmad Chaudry as the firm’s first Global Head of Structured Investments and Derivatives. This newly created role underscores Klay’s commitment to expanding its structured solutions platform and strengthening its global advisory capabilities.

 

Based in Dubai, Ahmad will lead the development of innovative solutions across all major asset classes with a strong focus on structured investments, liquidity management and hedging strategies.

 

Ahmad brings nearly 20 years of global investment banking experience in structuring and execution of bespoke solutions across equities, fixed income, commodities and liquid alternatives. He joins Klay Group from UBS Investment Bank in Hong Kong, where he most recently held a dual role as Co-Head of APAC Global Markets Structuring and Head of Global Markets Platform Solutions. Ahmad previously served in senior roles at UBS in London, NatWest Markets (formerly RBS Global Banking & Markets) and HSBC Investment.

 

Over his career, Ahmad has worked with a diverse client base including asset managers, insurance companies, pension funds, sovereign wealth funds, global family offices and private banks. His expertise spans across tactical trading ideas, innovative savings and retirement solutions, discretionary and systematic portfolio strategies and structuring access solutions to alternative investments.

 

Kalpesh Khakhria, Chairman of Klay Group, added: “Ahmad’s deep expertise in structured investments and his track record of delivering complex solutions to sophisticated clients will be a significant asset to our platform. His appointment reflects Klay’s continuous commitment to attracting top-tier talent to strengthen our capabilities and provide our clients with world-class advisory and investment solutions.”

 

Commenting on his appointment, Ahmad Chaudry said: “Klay’s commitment to delivering tailored, high-value solutions for its clients resonates deeply with my approach to investment structuring. I am excited to bring my global markets experience and work with the talented team here to create innovative strategies that meet the evolving needs of our clients.”

 

Ahmad holds a Bachelor’s degree in Aerospace Engineering from the University of Manchester and a Master’s degree in Quantitative Trading & Finance from Cass Business School.

 

About Klay Group:

Klay is a global boutique financial services firm delivering independent advice, tailored solutions, and smart systems across wealth management, multi-family office services, asset management, and corporate advisory. Combining institutional rigour with personalised service, our open architecture model ensures clients benefit from unbiased expertise, aligned incentives, and innovative insights powered by a dedicated in-house investment team and global analyst network.

 

With offices in Dubai, India, Singapore, London, and Australia, our diverse team of 140+ professionals from over 13 nationalities serves clients with a commitment to long-term relationships built on trust and shared success. Since inception, we have supported more than 450 families worldwide, maintaining a strong focus on bespoke strategies that preserve and grow wealth across generations.

 

Klay Group is regulated by the Dubai Financial Services Authority, the Monetary Authority of Singapore, the Securities and Exchange Board of India, the Financial Conduct Authority UK, and the Australian Securities and Investments Commission. Services are available to professional, accredited, and wholesale investors only.

Permalink

https://www.aetoswire.com/en/news/2092025487099

Contacts

Namita Thakkar - namita@matrixdubai.com

IFF Tackles Top Challenges in Baking at IBIE 2025

From commodity volatility to new regulations, IFF readies bakers with science-driven innovations and real-world demos.

 

(BUSINESS WIRE)--IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, health and biosciences, will showcase how it is helping the global baking industry overcome some of its toughest challenges at the International Baking Industry Exposition (IBIE) 2025 in Las Vegas. From soaring cocoa and egg prices to stricter regulations and rising demand for healthier baked goods, IFF is stepping forward with bold, science-led solutions designed to keep industrial bakers ahead of the curve.

“The industry is under pressure from every direction — supply chains, regulations and consumer expectations,” said Suzanne Pera, vice president and regional general manager for North America, IFF Food Ingredients. “Our message at IBIE is simple: Bakers don’t have to face these challenges alone. We bring unmatched expertise across the entire process, from formulation to shelf. We’re not just helping bakers adapt — we’re helping them win.”

Addressing the cost of volatility

With cocoa prices doubling and egg supplies remaining strained, IFF CURE™ — a comprehensive suite of Core and Uncommon Replacements and Extenders — offers solutions that maintain taste and texture while reducing reliance on volatile commodities. At the booth, visitors can sample 50 percent egg-reduced cupcakes and 30 percent cocoa-reduced brownies made with proprietary enzyme blends, system blends and natural flavors.

Navigating regulatory shifts

With certain food dyes now banned and the industry reevaluating what quantifies as “healthy,” bakers face increasing reformulation demands. IFF spotlights natural color alternatives, label-friendly hydrocolloids and shelf-life extension solutions that keep products compliant without sacrificing sensory appeal.

Meeting the health-conscious consumer

GLP-1 users are reshaping food and beverage demand, while shoppers broadly seek lower sugar, more protein and label-friendly bakery options. The prototypes reflect how IFF translates consumer and regulatory insights into market-ready products, featuring better-for-you concepts like high-protein tortillas and consumer-validated nutrition bars fortified with SOLAE^® SUPRO^® soy protein and LITESSE^® ULTRA prebiotic fiber.

Breakthrough baking technologies debut

IFF will debut DANISCO^® GRINDSTED^® Pectin FB 420, a bake-stable pectin made from citrus peels. This naturally sourced, label-friendly alternative to starch enhances flavor release and mouthfeel, while delivering a bright, glossy texture in reduced-sugar bakery applications. Also launching is POWERFRESH^® ACE 2000, a next-generation fresh-keeping enzyme that improves bread softness, resilience and cohesiveness for up to 34 days.

“We are not just displaying ingredients,” said Linda Dunning, applications director, North America, IFF Food Ingredients. “We are showing how real-world solutions can raise the game for bakers — ideas that work in the lab, are scalable in production and stand out on the shelf.”

Attendees will experience go-to-market applications, designed to inspire product innovations while solving some of the baking industry’s toughest challenges. IFF will be at IBIE 2025 from Sept. 14-17 at the Las Vegas Convention Center, booth 3855.

To learn more about IFF at IBIE and its bold, future-forward baking solutions, visit the IFF IBIE 2025 page here.

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ^SM or ^® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250902465856/en/

Permalink
https://aetoswire.com/en/news/2092025487355

Contacts

Jasmine Chia
Global Communications Director, Food Ingredients
+65 9827 3808
Jasmine.Chia@iff.com

Green Finance Tops the Agenda at the World Green Economy Summit 2025

Dubai, United Arab Emirates - Tuesday, 02. September 2025

In light of escalating environmental challenges and the global push to achieve net-zero goals, the 11th World Green Economy Summit (WGES) continues to serve as a vital platform for decision-makers, investors and experts from around the world. This year’s event comes at a critical time as rapid advances in artificial intelligence (AI) and data centres intersects with the urgent need to reshape the future of energy towards more sustainable and efficient alternatives. Sessions will explore financial mechanisms driving the green transition, address challenges in scaling up renewable energy and explore avenues for climate finance.

Held under the patronage of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, WGES is organised by the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) and the World Green Economy Organization (WGEO). Each year, the summit addresses key topics related to mobilising global efforts to accelerate the shift towards a green economy, in line with the UN Sustainable Development Goals 2030. The 2025 summit, themed ‘Innovating for Impact: Accelerating the Future of the Green Economy’, will run on 1-2 October at Dubai World Trade Centre.

HE Saeed Mohammed Al Tayer, Vice Chairman of the Dubai Supreme Council of Energy, MD&CEO of DEWA and Chairman of WGEO, said: “Global investments in clean technologies, including renewable energy, grids and storage, are projected to exceed USD2.2 trillion in 2025, double the investment in fossil fuels, within a total global investment of USD3.3 trillion. However, developing countries continue to face a significant financing gap, requiring an increase in annual clean energy investments from USD270 billion to approximately USD1.6 trillion by the early 2030s. This underscores the need for innovative international co-ordination to reduce capital costs and mitigate investment risks. The World Green Economy Summit reflects our commitment to supporting global efforts to achieve the transition to a comprehensive and sustainable green economy, based on innovation and effective partnerships, supporting Dubai's position as a global hub for climate action.”

WGES 2025 will focus on removing barriers to investment-ready green projects and enhancing risk-sharing mechanisms, such as guarantees from international financial institutions, to attract greater capital flows into sustainable initiatives.

Permalink

https://www.aetoswire.com/en/news/wges292025en

Contacts

Shaikha Almheiri, +971552288228

The LYCRA Company Goes “ALL IN” at Intertextile Shanghai

  WILMINGTON, Del. - Tuesday, 02. September 2025 AETOSWire 

Open-Concept Pavilion Showcases New Brand Positioning and Denim Innovation

 

(BUSINESS WIRE)--The LYCRA Company, a global leader in developing fiber and technology solutions for the apparel and personal care industries, returns to Intertextile Shanghai (Sept. 2–4) with an exclusive global sneak preview of its latest denim innovation.

For the first time, the company’s booth features an open-concept co-creation space designed to foster collaboration. Four key industry partners will join The LYCRA Company in this shared exhibit space, located in Hall 4.1 (Booth E56). This area is part of a larger 788-square-meter pavilion, which also includes 18 co-exhibitors. The impactful and visually striking design brings the new ALL IN LYCRA® brand positioning to life, creating an immersive experience for visitors.

ALL IN embodies what sets the LYCRA® brand apart – empowering customers in three critical ways:

Delivering differentiated fibers that create high-performance products.

Granting access to LYCRA® Labs and scientists committed to innovation and problem-solving.

Offering compelling joint storytelling through tailored joint marketing programs.

This new positioning highlights the company’s commitment to helping partners stay competitive with advanced fiber solutions that enhance their products' capabilities.

“Intertextile Shanghai is the perfect platform to demonstrate how we’re going ‘ALL IN’ with our customers,” said Jason Wang, vice president - Asia, at The LYCRA Company. “We designed our exhibit space to foster deeper collaboration and stronger partnerships while showcasing our innovative, market-relevant solutions.”

Visitors to The LYCRA Company’s booth can explore the following innovations firsthand:

LYCRA® VintageFX denim technology – Delivers vintage looks in low-stretch fabrics, combining lasting comfort and fit with heritage style.

Bio-derived LYCRA® EcoMade fiber – Made from a renewable feedstock, this drop-in solution is expected to deliver the same performance as original LYCRA® fiber when it launches this year.

LYCRA FitSense® denim technology – Adds targeted shaping and lift zones to denim without extra panels or seams for a customized fit.

COOLMAX® EcoMade fiber – Made from 100% textile waste or recycled PET, its moisture-wicking, quick-drying performance benefits are demonstrated with an interactive display.

THERMOLITE® EcoMade fiber – Uses 100% recycled materials to add lightweight warmth to a range of performance apparel.

The four partners in the open pavilion showcase LYCRA® fiber across the value chain—from yarn to finished garments:

Lianxingfa is expanding the range of applications for LYCRA® ADAPTIV fiber, while Shining showcases its performance differentiation; both offer visitors an immersive experience.

Trend Textile presents sustainable knits made with LYCRA® FiT400™ fiber.

Narik highlights seamless garments powered by LYCRA® fiber.

Guest speakers from denim partners will join representatives of The LYCRA Company in two presentations on September 3, highlighting our collaboration and ALL IN approach:

LYCRA® VintageFX denim technology with Advance Denim and Texhong

COOLMAX® fiber with SEAZON Denim

For more details on The LYCRA Company’s presence and activities at Intertextile Shanghai, visit its official event page.

About The LYCRA Company

The LYCRA Company is a leading global fiber and technology solutions provider to the apparel and personal care industries committed to offering sustainable products using renewable, pre-, and post-consumer recycled ingredients that reduce waste and help set the stage for circularity. Headquartered in Wilmington, Delaware, United States, it owns the LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX® and TACTEL® brands. The LYCRA Company adds value to its customers’ products by offering unique innovations that meet the consumer’s need for comfort and lasting performance. Learn more at lycra.com.

LYCRA®, LYCRA FitSense®, LYCRA® FiT400™, COOLMAX®, and THERMOLITE® are trademarks of The LYCRA Company.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250901230542/en/

Permalink

https://www.aetoswire.com/en/news/2092025487033

Contacts

Karie J. Ford

Karie.J.Ford@lycra.com

500 Global and dcamp Bridge Korea and Silicon Valley to Accelerate Startup Growth

 (BUSINESS WIRE) -- 500 Global, one of the world’s most active venture capital firms1, and dcamp, South Korea’s premier foundation dedicated to fostering entrepreneurship, today announced a strategic partnership aimed to accelerate Korean startups’ growth as they expand to the US market.

Leveraging their proven track of supporting promising founders, 500 Global and d.camp will identify Korean startups that are primed for international expansion and investment. Select startups will join the 500 Global Flagship Accelerator in Silicon Valley to deepen their understanding of the US market, connect with the local ecosystem and develop opportunities for growth.

Younghoon Park, CEO of dcamp, stated,

“Through this strategic partnership, we aim to bridge the best of Korea’s entrepreneurial spirit with Silicon Valley’s renowned ecosystem. Our mission at dcamp has always been to empower Korean startups with the right tools and opportunities. Partnering with 500 Global is a transformative step forward, equipping our entrepreneurs to excel on the global stage.”

This partnership builds on an established relationship stemming from 500’s early bet on Korea in 2012. Through its dedicated local funds and Seoul-based programs, 500 Global has supported startups like CardMonster - an AI-powered gaming studio connecting major IPs with the tabletop gaming market - in scaling globally. After seed investment from 500 Korea, CardMonster traveled to the US as part of the program's Immersion Trek, connected with GTM mentors from Stripe as well as AI hyperscalers, and will be presenting at the upcoming Flagship Demo Day in San Francisco on October 7th.

Christine Tsai, CEO and Founding Partner of 500 Global, remarked,

“Our partnership with dcamp underscores 500 Global’s long standing conviction that ambitious, talented founders exist all around the world. Korea’s vibrant startup ecosystem is positioned to make a global impact, and we’re excited to accelerate this potential by connecting Korean founders to the opportunities, resources, and networks of Silicon Valley and beyond.”

The partnership was publicly launched at a signing ceremony held at 500 Global’s Palo Alto headquarters on August 28, 2025, featuring Christine Tsai and Younghoon Park, symbolizing the commitment of both organizations to fostering global entrepreneurial success.

About 500 Global

500 Global is a multi-stage venture capital firm with $2.1B in assets under management2 that invests in founders building fast-growing technology companies. We focus on markets where technology, innovation, and capital can unlock long-term value and drive economic growth and development. 500 Global has backed over 5,000 founders representing more than 3,000 companies operating in 80+ countries. We have invested in more than 35+ companies valued at over $1 billion and 150+ companies valued at over $100 million (including private, public, and exited companies). In Korea alone, 500 Global has three dedicated funds and 80+ portfolio companies. Our 175+ team members are located in more than 25 countries and bring experience as entrepreneurs, investors, and operators from some of the world’s leading technology companies.

About dcamp

​​dcamp is a startup growth support platform established under the Banks Foundation for Young Entrepreneurs, funded by donations from Korea’s 19 financial institutions. As its slogan ‘Startup Growth Partner’ suggests, dcamp provides investment and incubation infrastructure on a comprehensive scale to help entrepreneurs achieve explosive growth. Since its establishment in 2012, dcamp has actively driven the growth of early-stage startups. In 2024, it launched ‘dcamp 2.0,’ renewing its strategy to accelerate startups in the pre-A and Series A stages. It selects a maximum of 10 startups every quarter – with a focus on ICT, deep-tech, and climate-tech – and provides intricate and customized support to help them overcome the "Death Valley" phase. dcamp helps startups overcome growth pains and reach new heights by offering a wide spectrum of resources including equity investment, fund investment, office space, educational programs, talent recruitment, networking, promotional support, and global expansion.

THE CONTENT IN THIS PRESS RELEASE IS PROVIDED FOR GENERAL INFORMATIONAL OR EDUCATIONAL PURPOSES ONLY. 500 GLOBAL MAKES NO REPRESENTATIONS AS TO THE ACCURACY OR INFORMATION CONTAINED HEREIN AND WHILE 500 GLOBAL HAS TAKEN REASONABLE STEPS TO ENSURE THAT THE INFORMATION CONTAINED HEREIN IS ACCURATE AND UP-TO-DATE, NO LIABILITY CAN BE ACCEPTED FOR ANY ERROR OR OMISSIONS.

UNDER NO CIRCUMSTANCES SHOULD ANY OF THE CONTENT IN THIS PRESS RELEASE BE CONSTRUED AS LEGAL, TAX OR INVESTMENT ADVICE FROM 500 GLOBAL OR ANY OF ITS AFFILIATES. 500 GLOBAL DOES NOT GUARANTEE ANY FUTURE RESULTS FOR ANY DECISIONS MADE BASED IN WHOLE OR IN PART ON THE CONTENT OR INFORMATION CONTAINED HEREIN. ALL READERS OF THIS PRESS RELEASE SHOULD CONSULT WITH THEIR OWN COUNSEL, ACCOUNTANT OR OTHER PROFESSIONAL ADVISORS BEFORE TAKING ANY ACTION IN CONNECTION WITH THIS PRESS RELEASE.

UNDER NO CIRCUMSTANCES SHOULD ANY INFORMATION OR CONTENT IN THIS PRESS RELEASE, BE CONSIDERED AS AN OFFER TO SELL OR SOLICITATION OF INTEREST TO PURCHASE ANY SECURITIES ADVISED BY 500 GLOBAL OR ANY OF ITS AFFILIATES OR REPRESENTATIVES. FURTHER, NO CONTENT OR INFORMATION CONTAINED IN THIS PRESS RELEASE IS OR IS INTENDED AS AN OFFER TO PROVIDE ANY INVESTMENT ADVISORY SERVICE OR FINANCIAL ADVICE BY 500 GLOBAL. UNDER NO CIRCUMSTANCES SHOULD ANYTHING HEREIN BE CONSTRUED AS FUND MARKETING MATERIALS BY PROSPECTIVE INVESTORS CONSIDERING AN INVESTMENT INTO ANY 500 GLOBAL INVESTMENT FUND. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT BE INTERPRETED AS TESTIMONIALS OR ENDORSEMENT OF THE INVESTMENT PERFORMANCE OF ANY 500 GLOBAL FUND BY A PROSPECTIVE INVESTOR CONSIDERING AN INVESTMENT INTO ANY 500 GLOBAL INVESTMENT FUND.

___________________

1 Based on PitchBook’s 2024 Global League Tables.

2 ASSETS UNDER MANAGEMENT (AUM) CALCULATIONS ARE BASED ON INTERNAL ESTIMATES AS OF MARCH 31, 2025.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250831333378/en/

Permalink

https://www.aetoswire.com/en/news/0109202548698

Contacts

Media Contacts

Media Relations at 500 Global

press@500.co

 

WETEX opens broad investment horizons for international companies

Dubai, United Arab Emirates - Sunday, 31. August 2025

DEWA will organise the exhibition from 30 September to 2 October 2025
 

Under the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, Dubai Electricity and Water Authority (DEWA) will organise the 27th edition of the Water, Energy, Technology and Environment Exhibition (WETEX) from 30 September to 2 October 2025 at the Dubai World Trade Centre.

WETEX embodies the UAE's pioneering position in clean and renewable energy and sustainability. It also supports Dubai's ambitious vision of a sustainable economy. The exhibition covers multiple areas including water, energy, smart cities, green mobility, artificial intelligence and digital transformation.

“WETEX reflects the UAE's unwavering commitment to sustainability and strengthens Dubai's position as a leading global green economy hub. The exhibition has established itself as one of the world's leading specialised events, providing a platform to showcase the latest innovations in clean energy, water and sustainability. It also supports building partnerships that contribute to achieving global climate goals and accelerating the transition to a green economy. WETEX annually brings together industry leaders, investors, innovators and government officials from around the world to share knowledge, explore opportunities and collaborate in building a more sustainable and resilient future,” said HE Saeed Mohammed Al Tayer, MD & CEO of DEWA and Founder and Chairman of WETEX.

WETEX is a leading platform that brings together organisations from the government and private sectors to explore the latest innovations, build cross-sectoral partnerships, enhance co-operation in sustainability and energy transformation, as well as support global efforts to adapt to climate change. WETEX also provides a strategic opportunity for international companies and organisations wishing to enter new markets and conclude investment deals within one of the green economies most prepared for the future.

Since its launch, WETEX has witnessed rapid growth. In 2024, it welcomed 50,598 visitors and more than 2,800 exhibitors from 65 countries, and featured 21 international pavilions. WETEX 2025 will provide exceptional access to international markets, promote cross-border dialogue and pave the way for tangible results through partnerships, innovation and investment.

Visitors and exhibitors can register and get more information at https://www.wetex.ae/en

Permalink
https://www.aetoswire.com/en/news/wtx3182025

Contacts

Shaikha Almheiri, +971552288228